The story of Viagra and the medicinal industry presents a intricate picture for careful investors. Initially, copyright's blockbuster drug transformed the treatment of erectile dysfunction, producing significant profits and defining the contemporary pharmaceutical landscape. However, patent expiration and the rise of alternative versions have drama